Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer
出版年份 2022 全文链接
标题
Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer
作者
关键词
-
出版物
Scientific Reports
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-06-16
DOI
10.1038/s41598-022-14097-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma
- (2021) Jie Shen et al. LABORATORY INVESTIGATION
- Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma
- (2021) Yi Jin et al. Frontiers in Immunology
- miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
- (2021) Maria Teresa Di Martino et al. Cancers
- Identification of three m6A‐related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma
- (2020) Zedong Li et al. Cancer Medicine
- VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer
- (2020) Daniela Barros-Silva et al. Cancers
- RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription
- (2020) Jianjun Wang et al. Gastric Cancer
- Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer
- (2020) Faping Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Novel insights into the interplay between m6A modification and noncoding RNAs in cancer
- (2020) You-Cai Yi et al. Molecular Cancer
- Crosstalk between RNA m6A modification and non-coding RNA contributes to cancer growth and progression
- (2020) Fengsheng Dai et al. Molecular Therapy-Nucleic Acids
- The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
- (2020) Zibo Meng et al. Molecular Therapy-Oncolytics
- Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
- (2020) Yejinpeng Wang et al. Cancer Medicine
- Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma
- (2020) Lilan Yi et al. Molecular Therapy-Nucleic Acids
- Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation
- (2020) Marc A. J. Morgan et al. NATURE GENETICS
- RNA methylations in human cancers
- (2020) Xiao Han et al. SEMINARS IN CANCER BIOLOGY
- The Critical Role of RNA m6A Methylation in Cancer
- (2019) Qing Lan et al. CANCER RESEARCH
- Cellular functions of long noncoding RNAs
- (2019) Run-Wen Yao et al. NATURE CELL BIOLOGY
- Interplay Between N6-Methyladenosine (m6A) and Non-coding RNAs in Cell Development and Cancer
- (2019) Francesco Fazi et al. Frontiers in Cell and Developmental Biology
- Prognostic value of long non-coding RNA signatures in bladder cancer
- (2019) Anbang He et al. Aging-US
- An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer
- (2019) Penghu Lian et al. Aging-US
- Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer
- (2018) Bernadett Szabados et al. EUROPEAN UROLOGY
- m6A RNA Methylation Controls Neural Development and Is Involved in Human Diseases
- (2018) Kunzhao Du et al. MOLECULAR NEUROBIOLOGY
- N6-methyladenosine links RNA metabolism to cancer progression
- (2018) Dongjun Dai et al. Cell Death & Disease
- Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location
- (2018) Longhui Zhang et al. Frontiers in Immunology
- Targeting Macrophages in Cancer: From Bench to Bedside
- (2018) Ashleigh R. Poh et al. Frontiers in Oncology
- NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
- (2018) Di Huang et al. NATURE IMMUNOLOGY
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
- (2018) Shuai Zhen et al. HUMAN GENE THERAPY
- Long noncoding RNA s as regulators of cancer immunity
- (2018) Nerina Denaro et al. Molecular Oncology
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- m 6 A in mRNA: An Ancient Mechanism for Fine-Tuning Gene Expression
- (2017) Jean-Yves Roignant et al. TRENDS IN GENETICS
- The long non-coding RNA LINC01013 enhances invasion of human anaplastic large-cell lymphoma
- (2017) I-Hsiao Chung et al. Scientific Reports
- CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages
- (2016) I. De et al. CANCER RESEARCH
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
- (2016) Samantha Cambier et al. EUROPEAN UROLOGY
- METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulatingN6-methyladenosine-dependent primary MicroRNA processing
- (2016) Jin-zhao Ma et al. HEPATOLOGY
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Emerging immunotherapies for bladder cancer
- (2015) Joseph W. Kim et al. CURRENT OPINION IN ONCOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Macrophages and cancer: from mechanisms to therapeutic implications
- (2015) Renato Ostuni et al. TRENDS IN IMMUNOLOGY
- Cancer stem cells in progression of colorectal cancer
- (2015) Yujuan Zhou et al. Oncotarget
- Macrophages are recruited to hypoxic tumor areas and acquire a Pro-Angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin
- (2015) Chakrapani Tripathi et al. Oncotarget
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process
- (2014) Y. Wu et al. JOURNAL OF IMMUNOLOGY
- DNA Methylation and Cancer Development: Molecular Mechanism
- (2013) Haleh Akhavan-Niaki et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- CCL2 and Interleukin-6 Promote Survival of Human CD11b+Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization
- (2009) Hernan Roca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started